VAERS Explorer
Back to explore

Report #2889437

Received Mar 17, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
37 yrs
State
CA
Recovered
Unknown
Vaccinated
Jan 31, 2026
Onset
Jan 1, 2026
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK4434AIM / LA

Symptoms (3)

Exposure during pregnancyNo adverse eventProduct use issue

Symptom narrative

Patient pregnant, due 3/25/26. Patient received the Arexvy vaccine at 32 weeks gestation. No adverse events associated with this administration. Patient will be notified that infant may need RSV vaccine when born, since Arexvy does not offer the protection that Abrysvo would have offered .

Lab data

NA